Oligomycin sensitivity of mitochondrial F1F0-ATPase in diabetes-prone BHE/Cdb rats

被引:14
|
作者
Kim, SB [1 ]
Berdanier, CD [1 ]
机构
[1] Univ Georgia, Dept Foods & Nutr, Athens, GA 30602 USA
关键词
oxidative phosphorylation; mitochondria; diabetes;
D O I
10.1152/ajpendo.1999.277.4.E702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oligomycin sensitivity of mitochondrial F1F0-ATPase in diabetes-prone BHE/Cdb rats. BHE/Cdb and Sprague-Dawley rats differ in their mitochondrial DNA sequence for the ATPase 6 ("subunit a") gene. Base substitutions in this sequence result in the substitution of asparagine for aspartate at position 101 and the substitution of serine for leucine at position 129. Differences in sensitivity to oligomycin were observed. When the isolated F1F0-ATPase complex was studied and ATPase activity was assessed, that which was isolated from the BHE/Cdb rats was less sensitive to oligomycin inhibition than that which was isolated from the Sprague-Dawley rats. In contrast, when oxygen consumption was measured [oxygen phosphorylation (OXPHOS)] and a dose-response curve was generated with isolated mitochondria from these two strains, there was a shift to the left for the BHE/Cdb rat mitochondria. These mitochondria were more sensitive to oligomycin inhibition of OXPHOS than were mitochondria isolated from Sprague-Dawley rats. The OXPHOS results are consistent with those from human fibroblasts having either a normal or mutated ATPase 6 gene.
引用
收藏
页码:E702 / E707
页数:6
相关论文
共 50 条
  • [41] Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423
    Johnson, KM
    Chen, XN
    Boitano, A
    Swenson, L
    Opipari, AW
    Glick, GD
    CHEMISTRY & BIOLOGY, 2005, 12 (04): : 485 - 496
  • [42] Chemical crosslinking of the c subunit of Escherichia coli F1F0-ATPase
    Glavas, N
    Walker, JE
    ACTA PHYSIOLOGICA SCANDINAVICA, 1998, 163 : 335 - 335
  • [43] Reversible ischemic inhibition of F1F0-ATPase in rat and human myocardium
    Ylitalo, K
    Ala-Rämi, A
    Vuorinen, K
    Peuhkurinen, K
    Lepojärvi, M
    Kaukoranta, P
    Kiviluoma, K
    Hassinen, I
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2001, 1504 (2-3): : 329 - 339
  • [44] The dimerization domain of the b subunit of the Escherichia coli F1F0-ATPase
    Revington, M
    McLachlin, DT
    Shaw, GS
    Dunn, SD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 31094 - 31101
  • [45] MUTANTS IN SUBUNIT-A OF THE ESCHERICHIA-COLI F1F0-ATPASE
    PAULE, CR
    FILLINGAME, RH
    BIOPHYSICAL JOURNAL, 1990, 57 (02) : A352 - A352
  • [46] Oligomycin, an F1F0-ATPase Inhibitor, Protects Against Ischemic Acute Kidney Injury in Male but Not in Female Rats (Retraction of vol 123, pg 227, 2013)
    Tanaka, Ryosuke
    Takayama, Junji
    Takaoka, Masanori
    Sugino, Yohko
    Ohkita, Mamoru
    Matsumura, Yasuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 126 (03) : 291 - 291
  • [47] Dimerization interactions of the b subunit of the Escherichia coli F1F0-ATPase
    McLachlin, DT
    Dunn, SD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) : 21233 - 21239
  • [48] MOLECULAR-BIOLOGY OF THE F1F0-ATPASE OF ESCHERICHIA-COLI
    GIBSON, F
    PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY, 1984, 16 : S47 - S47
  • [49] SPECTRAL PROPERTIES OF FLUORESCENT DERIVATIVES OF THE OLIGOMYCIN SENSITIVITY CONFERRING PROTEIN AND ANALYSIS OF THEIR INTERACTION WITH THE F1 AND F0 SECTORS OF THE MITOCHONDRIAL ATPASE COMPLEX
    DUSZYNSKI, J
    DUPUIS, A
    LUX, B
    VIGNAIS, PV
    BIOCHEMISTRY, 1988, 27 (17) : 6288 - 6296
  • [50] F1F0-ATPASE AS AN AUTOANTIGENIC TARGET IN PATIENTS WITH ANTI-MITOCHONDRIAL ANTIBODY NEGATIVE PRIMARY BILIARY CIRRHOSIS
    Mytilinaiou, Maria G.
    Komorowski, Lars
    Rigopoulou, Eirini I.
    Janssen, Anthonina
    Probst, Christian
    Vergani, Diego
    Bogdanos, Dimitrios P.
    HEPATOLOGY, 2010, 52 (04) : 493A - 493A